These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 27150987

  • 1. [Expression of CD25 in Acute Myeloid Leukemia Is An Adverse Prognostic Factor Independent of the Chromosome Karyotype].
    Liu YF, Dong L, Wang C, Sun H, Zhang QT, Wang M, Li T, Xu Y, Ma J, Xie XS, Sun L, Wan DM.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):332-5. PubMed ID: 27150987
    [Abstract] [Full Text] [Related]

  • 2. CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia.
    Fujiwara SI, Muroi K, Yamamoto C, Hatano K, Okazuka K, Sato K, Oh I, Ohmine K, Suzuki T, Ozawa K.
    Hematology; 2017 Jul; 22(6):347-353. PubMed ID: 28097942
    [Abstract] [Full Text] [Related]

  • 3. [Clinical features and early treatment effects in intermediate risk and poor risk acute myeloid leukemia with EVI1 positive].
    Duan WB, Gong LZ, Jia JS, Zhu HH, Zhao XS, Jiang Q, Zhao T, Wang J, Qin YZ, Huang XJ, Jiang H.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Dec 18; 49(6):990-995. PubMed ID: 29263470
    [Abstract] [Full Text] [Related]

  • 4. CD25 expression on residual leukemic blasts at the time of allogeneic hematopoietic stem cell transplant predicts relapse in patients with acute myeloid leukemia without complete remission.
    Ikegawa S, Doki N, Kurosawa S, Yamaguchi T, Sakaguchi M, Harada K, Yamamoto K, Hino Y, Shingai N, Senoo Y, Hattori K, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Haraguchi K, Okuyama Y, Ohashi K.
    Leuk Lymphoma; 2016 Dec 18; 57(6):1375-81. PubMed ID: 26422713
    [Abstract] [Full Text] [Related]

  • 5. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
    Hasserjian RP, Campigotto F, Klepeis V, Fu B, Wang SA, Bueso-Ramos C, Cascio MJ, Rogers HJ, Hsi ED, Soderquist C, Bagg A, Yan J, Ochs R, Orazi A, Moore F, Mahmoud A, George TI, Foucar K, Odem J, Booth C, Morice W, DeAngelo DJ, Steensma D, Stone RM, Neuberg D, Arber DA.
    Am J Hematol; 2014 Nov 18; 89(11):E193-9. PubMed ID: 25042343
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Prognostic Value of CD123 in Acute Myeloid Leukemia Patients with Intermediate Risk in Normal Karyotype].
    Zhang Y, Liu RY, Wang SJ, Wang C, Zhang QT, He C, Xie XS, Wan DM, Jiang ZX, Liu YF.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec 18; 28(6):1880-1884. PubMed ID: 33283714
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Prognostic factor analysis of 77 old patients with acute myelogenous leukemia].
    Shao B, Gao YR, Wang C, Yan SK, Cai Q, Jiang JL, Yang J, Bai HT, Zhao M, Zhao CX.
    Ai Zheng; 2006 Aug 18; 25(8):1007-12. PubMed ID: 16965684
    [Abstract] [Full Text] [Related]

  • 10. Clinical value of CD25/CD123 co-expression in acute myeloid leukemia patients.
    Aref S, Azmy E, El Ghannam D, Haroun M, Ibrahim L, Sabry M.
    Cancer Biomark; 2020 Aug 18; 29(1):9-16. PubMed ID: 32417762
    [Abstract] [Full Text] [Related]

  • 11. Elevated frequencies of CD4⁺ CD25⁺ CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia.
    Shenghui Z, Yixiang H, Jianbo W, Kang Y, Laixi B, Yan Z, Xi X.
    Int J Cancer; 2011 Sep 15; 129(6):1373-81. PubMed ID: 21105040
    [Abstract] [Full Text] [Related]

  • 12. CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900.
    Gönen M, Sun Z, Figueroa ME, Patel JP, Abdel-Wahab O, Racevskis J, Ketterling RP, Fernandez H, Rowe JM, Tallman MS, Melnick A, Levine RL, Paietta E.
    Blood; 2012 Sep 13; 120(11):2297-306. PubMed ID: 22855599
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
    El-Sharnouby JA, Ahmed LM, Taha AM, Kamal O.
    Egypt J Immunol; 2008 Sep 13; 15(1):131-43. PubMed ID: 20306678
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML.
    Terwijn M, Feller N, van Rhenen A, Kelder A, Westra G, Zweegman S, Ossenkoppele G, Schuurhuis GJ.
    Eur J Cancer; 2009 Jun 13; 45(9):1692-9. PubMed ID: 19321337
    [Abstract] [Full Text] [Related]

  • 15. [IDH1 Gene Mutation and Its Clinical Significance in patients with Acute Myeloid Leukemia].
    Wei JF, Qiu HY, Chen GH, Wang Y, Chen Z, Liu HJ, Mao JP, Jia T, Xue LG, Cai ZM, Zhu YX, Zhao LD.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct 13; 23(5):1252-7. PubMed ID: 26524018
    [Abstract] [Full Text] [Related]

  • 16. Prognostic Parameters of Acute Myeloid Leukaemia at Presentation.
    Jahic A, Iljazovic E, Hasic S, Arnautovic AC, Sabitovic D, Mesanovic S, Sahovic H, Simendic V.
    Med Arch; 2017 Feb 13; 71(1):20-24. PubMed ID: 28428668
    [Abstract] [Full Text] [Related]

  • 17. CD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabine.
    Allan JN, Roboz GJ, Askin G, Ritchie E, Scandura J, Christos P, Hassane DC, Guzman ML.
    Leuk Lymphoma; 2018 Apr 13; 59(4):821-828. PubMed ID: 28718760
    [Abstract] [Full Text] [Related]

  • 18. [Therapeutic Response and Prognosis of Adult Acute Myeloid Leukemia with Chromosome Karyotype Abnormalities].
    Chen Y, Tao SD, Shi YY, Song LX, Deng Y, Ling LL, Ding BH, Chen KK, He ZM, Wang CL, Yu L.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec 13; 27(6):1717-1721. PubMed ID: 31839028
    [Abstract] [Full Text] [Related]

  • 19. Multivariate analyses of prognostic factors in acute myeloid leukemia: relevance of cytogenetic abnormalities and CD34 expression.
    Junghanss C, Waak M, Knopp A, Kleine HD, Kundt G, Leithäuser M, Hilgendorf I, Wolff D, Casper J, Freund M.
    Neoplasma; 2005 Dec 13; 52(5):402-10. PubMed ID: 16151585
    [Abstract] [Full Text] [Related]

  • 20. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D, Chelghoum Y, Le QH, Elhamri M, Michallet M, Thomas X.
    Ann Hematol; 2003 Nov 13; 82(11):684-90. PubMed ID: 12928754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.